Dr. Haseeb A. Khan is a Distinguished Professor at the Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia. He is Group Leader of Analytical and Molecular Bioscience Research Group and Chair Professor at Research Chair for Biomedical Applications of Nanomaterials. He completed his PhD from India and received trainings at USA, UK, France, Denmark and Finland. He made significant contribution in bridging gaps between chemistry, biology, computation and medical sciences. He discovered dual biomarker potential of HbA1c for glycemic control and dyslipidemia. This pioneering research compelled the Japanese pharmaceutical company, Kissei Pharmaceuticals, to display his data in their product brochures. He identified novel SNPs in carnitine transporter gene and discovered the role of carnitine homeostasis in heart disease. His innovative research includes the development of methods for analysis of ATP, GFAP and tyrosine hydroxylase in mouse brain; efficient extraction of skin lipids; computer-aided quantification of gastric ulcers in rats, immunological response of nanomaterials, and novel therapies for cancer. He developed 8 software tools for biomedical applications, which were published and demanded by >300 scientists from 45 countries. The factorial equation developed by him has been utilized by scientists from Emory University, USA and Swinburne University, Australia for creating their own bioinformatics tools. He is a recipient of Microsoft eScience Award and listed in Top-2% world ranking of scientists.